Jia Tolentino on the Ozempic Weight-Loss Craze

The New Yorker Radio Hour

24-03-2023 • 17 mins

The prescription drug Ozempic was designed to help people with Type 2 diabetes manage their disease, and, under the name Wegovy, to treat obesity. But it has been embraced recently as a tool for weight loss, and many celebrities are rumored to use it in order to shed pounds. Known generically as semaglutide, the drug gives users the feeling of satiation—even to the point of uncomfortable fullness. “One doctor I spoke to compared it to a turkey dinner in a pen,” the staff writer Jia Tolentino tells David Remnick. Tolentino recently reported on the use and misuse of the drug, and what its prominence among celebrities says about our relationship to thinness today. After some years in which body culture seemed to become more accepting, Tolentino fears the drug will wind the clock back to the brutal insistence on thinness of decades past. “Like any technology, it’s very complicated,” she says. “For some people, this drug might save their lives. For others, it does not make sense to be used in any casual way.”

You Might Like

The Morning Brief
The Morning Brief
The Economic Times
ANI Podcast with Smita Prakash
ANI Podcast with Smita Prakash
Asian News International (ANI)
ThePrint
ThePrint
ThePrint
3 Things
3 Things
Express Audio
FT News Briefing
FT News Briefing
Financial Times
Top of the Morning
Top of the Morning
Mint - HT Smartcast
Economist Podcasts
Economist Podcasts
The Economist
HT Daily News Wrap
HT Daily News Wrap
Hindustan Times - HT Smartcast
Daybreak
Daybreak
The Ken
The Daily
The Daily
The New York Times
The Journal.
The Journal.
The Wall Street Journal & Gimlet
Serial
Serial
Serial Productions & The New York Times
WSJ What’s News
WSJ What’s News
The Wall Street Journal
WSJ Tech News Briefing
WSJ Tech News Briefing
The Wall Street Journal
The Signal Daily
The Signal Daily
The Core Team